Kodiak Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.About KOD
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.
CEOVictor Perlroth
CEOVictor Perlroth
Employees109
Employees109
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2009
Founded2009
Employees109
Employees109
KOD Key Statistics
Market cap1.31B
Market cap1.31B
Price-Earnings ratio-6.01
Price-Earnings ratio-6.01
Dividend yield—
Dividend yield—
Average volume701.43K
Average volume701.43K
High today$24.76
High today$24.76
Low today$22.50
Low today$22.50
Open price$22.65
Open price$22.65
Volume648.14K
Volume648.14K
52 Week high$24.76
52 Week high$24.76
52 Week low$1.92
52 Week low$1.92
Stock Snapshot
Kodiak Sciences(KOD) stock is priced at $24.76, giving the company a market capitalization of 1.31B. It carries a P/E multiple of -6.01.
On 2025-12-04, Kodiak Sciences(KOD) stock moved within a range of $22.50 to $24.76. With shares now at $24.76, the stock is trading +10.0% above its intraday low and 0.0% below the session's peak.
Trading volume for Kodiak Sciences(KOD) stock has reached 648.14K, versus its average volume of 701.43K.
Over the past 52 weeks, Kodiak Sciences(KOD) stock has traded between a high of $24.76 and a low of $1.92.
Over the past 52 weeks, Kodiak Sciences(KOD) stock has traded between a high of $24.76 and a low of $1.92.
Analyst ratings
57%
of 7 ratingsBuy
57.1%
Hold
28.6%
Sell
14.3%
People also own
Based on the portfolios of people who own KOD. This list is generated using Robinhood data, and it’s not a recommendation.